Sentis™ is a screening test for hereditary breast and ovarian cancer.  Sentis™ provides health providers and patients with information relating to 21 genes, which have been linked to Breast Cancer or Ovarian Cancer, including the tumour suppressor genes BRCA1/2. This enables the development of patient-specific medical management plans that can prevent or delay the onset of cancer, or detect it at an earlier and more treatable stage.